Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib - A phase II trial (PEMRAD)
帕博利珠单抗联合立体定向放射治疗索拉非尼治疗后晚期肝细胞癌——一项 II 期试验 (PEMRAD)
期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2025.101658
O'Kane, Grainne M; Mesci, Aruz; Jang, Raymond W; Barry, Aisling; Bocaya, Cynthia M; Boukhaled, Giselle M; Acton, Holly; Doddington, David; Rodrigo, Rowena; Chan, Leo M L; Noamani, Babak; Harvey, Harry; Elia, Andrew; Law, Rhoda; Prince, Rebecca; Doherty, Mark; Dodd, Anna; Wong, David K; Wang, Lisa; Wang, Ben X; Chen, Eric X; Dawson, Laura A; Knox, Jennifer J